β Coefficient | Standard error | p-value | |
Duration of treatment | |||
First month | ref | ||
Third month | 11.706 | 0.793 | <0.001 |
Sixth month | 27.695 | 0.794 | <0.001 |
Therapeutic regimen | |||
Only aminoglycosides | ref | ||
Only bedaquiline | −2.169 | 2.689 | 0.420 |
Received aminoglycosides followed by bedaquiline | −6.843 | 2.550 | 0.007 |
Age | |||
<40 years | ref | ||
≥40 years | 6.102 | 1.779 | <0.001 |
Sex | |||
Female | ref | ||
Male | −0.507 | 1.855 | 0.785 |
Body mass index | |||
≥18.5 | ref | ||
<18.5 | 1.989 | 1.631 | 0.223 |
Alcohol intake | |||
No | ref | ||
Yes | 2.469 | 1.879 | 0.189 |
Hypertension | |||
No | ref | ||
Yes | −1.866 | 4.412 | 0.672 |
Hemoglobin | |||
Normal | |||
Anemia | −1.008 | 2.214 | 0.649 |
Albumin | |||
Normal | |||
Hypoalbuminemia | 5.610 | 1.682 | 0.001 |
HIV status | |||
Negative | ref | ||
Positive | −1.435 | 2.618 | 0.583 |
CKD | |||
Stage I | ref | ||
Stage II | −1.993 | 1.891 | 0.292 |
Stage III and over | 6.730 | 2.710 | 0.013 |